Precipio Inc PRPO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
6.05quote price arrow up+0.28 (+4.78%)
Volume
7,987
52 week range
4.75 - 14.80
Loading...
  • Open5.93
  • Day High6.27
  • Day Low5.83
  • Prev Close5.77
  • 52 Week High14.80
  • 52 Week High Date06/07/23
  • 52 Week Low4.75
  • 52 Week Low Date09/22/23

Key Stats

  • Market Cap8.891M
  • Shares Out1.47M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.28
  • YTD % Change-7.15

KEY STATS

  • Open5.93
  • Day High6.27
  • Day Low5.83
  • Prev Close5.77
  • 52 Week High14.80
  • 52 Week High Date06/07/23
  • 52 Week Low4.75
  • 52 Week Low Date09/22/23
  • Market Cap8.891M
  • Shares Out1.47M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.28
  • YTD % Change-7.15

RATIOS/PROFITABILITY

  • EPS (TTM)-4.87
  • P/E (TTM)-1.24
  • Fwd P/E (NTM)-4.73
  • EBITDA (TTM)-6.395M
  • ROE (TTM)-38.09%
  • Revenue (TTM)15.197M
  • Gross Margin (TTM)39.60%
  • Net Margin (TTM)-38.51%
  • Debt To Equity (MRQ)3.40%

EVENTS

  • Earnings Date05/15/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Precipio Inc

 

Profile

MORE
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Company’s technologies include HemeScreen and IV-Cell. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables...
Richard Sandberg
Independent Chairman of the Board
Ilan Danieli
Chief Executive Officer, Founder, Director
Ahmed Zaki Sabet
Chief Operations Officer
Matthew Gage
Interim Chief Financial Officer
Ayman Mohamed M.D.
Chief Technology Officer, Vice President - Research & Development
Address
12325 Emmet St
Omaha, NE
68164-4243
United States